Ginkgo Bioworks Holdings Stock Investor Sentiment
DNA Stock | USD 14.73 1.18 8.71% |
About 62% of Ginkgo Bioworks' investor base is looking to short. The analysis of the overall investor sentiment regarding Ginkgo Bioworks Holdings suggests that many traders are alarmed. The current market sentiment, together with Ginkgo Bioworks' historical and current headlines, can help investors time the market. In addition, many technical investors use Ginkgo Bioworks Holdings stock news signals to limit their universe of possible portfolio assets.
Comfort Level 38
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ginkgo Bioworks' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ginkgo Bioworks Holdings.
News SentimentNeutral | Hype SentimentBullish | Insider SentimentDisposing |
Ginkgo Historical Sentiment
Although Ginkgo Bioworks' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Ginkgo, such as negative comments on social media and news outlets, may cause fear in the market and push Ginkgo Bioworks' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Ginkgo.
Ginkgo |
Ginkgo Bioworks Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Ginkgo Bioworks can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Ginkgo Bioworks Holdings Historical Investor Sentiment
Investor biases related to Ginkgo Bioworks' public news can be used to forecast risks associated with an investment in Ginkgo. The trend in average sentiment can be used to explain how an investor holding Ginkgo can time the market purely based on public headlines and social activities around Ginkgo Bioworks Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ginkgo Bioworks' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ginkgo Bioworks and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ginkgo Bioworks news discussions. The higher the estimate score, the more favorable the investor's outlook on Ginkgo Bioworks.
Ginkgo Bioworks Maximum Pain Price Across March 21st 2025 Option Contracts
Ginkgo Bioworks' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Ginkgo Bioworks close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Ginkgo Bioworks' options.
Far too much social signal, news, headlines, and media speculation about Ginkgo Bioworks that are available to investors today. That information is available publicly through Ginkgo media outlets and privately through word of mouth or via Ginkgo internal channels. However, regardless of the origin, that massive amount of Ginkgo data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ginkgo Bioworks news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ginkgo Bioworks relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ginkgo Bioworks' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ginkgo Bioworks alpha.
Ginkgo Bioworks Performance against Dow Jones
Price Growth (%) |
Timeline |
1 | CORRECTING and REPLACING Publication in NPJ Vaccines Highlights Benefits of Stratis Intramuscular Delivery of DNA Vaccine for Hantaviruses | 12/11/2024 |
2 | Previously unusable DNA samples entered as evidence in trial of quadruple killings in NJ mansion | 12/27/2024 |
3 | Disposition of 450 shares by Mark Dmytruk of Ginkgo Bioworks subject to Rule 16b-3 | 01/03/2025 |
4 | Disposition of 645 shares by Mark Dmytruk of Ginkgo Bioworks at 11.718 subject to Rule 16b-3 | 01/06/2025 |
5 | Direct link found between eating fiber and anti-cancer effects which foods are best | 01/14/2025 |
6 | Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center | 01/23/2025 |
7 | Ginkgo Bioworks Holdings, Inc. Stock Position Reduced by Exchange Traded Concepts LLC - MarketBeat | 01/27/2025 |
8 | Ginkgo Bioworks Upgraded to Strong Buy Heres What You Should Know | 01/29/2025 |
9 | Vanguard Group Inc Reduces Stake in Ginkgo Bioworks Holdings Inc | 01/31/2025 |
10 | Disposition of 454 shares by Mark Dmytruk of Ginkgo Bioworks subject to Rule 16b-3 | 02/03/2025 |
11 | Disposition of 740 shares by Mark Dmytruk of Ginkgo Bioworks at 13.443 subject to Rule 16b-3 | 02/04/2025 |
12 | Africa and Europe Join Forces to Revolutionize RNA-based Vaccines and Therapeutics Production MoU Signed Between EVA Pharma, DNA Script, Quantoom Biosciences | 02/05/2025 |
13 | Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14 | 02/11/2025 |
14 | Mimulus Technologies and Expand Entertainment Partner to Provide Advanced DNA Data Storage Solutions | 02/13/2025 |
15 | DNA from Fiserv Selected by Third Federal as Part of its Digital Transformation | 02/14/2025 |
Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |